- Home
- UONE vs ABOS Comparison
UONE vs ABOS Comparison
Compare UONE & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONE
- ABOS
- Stock Information
- Founded
- UONE 1980
- ABOS 1996
- Country
- UONE United States
- ABOS United States
- Employees
- UONE N/A
- ABOS N/A
- Industry
- UONE Broadcasting
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- UONE Consumer Discretionary
- ABOS Health Care
- Exchange
- UONE Nasdaq
- ABOS Nasdaq
- Market Cap
- UONE 70.8M
- ABOS 84.2M
- IPO Year
- UONE N/A
- ABOS 2021
- Fundamental
- Price
- UONE $1.46
- ABOS $1.25
- Analyst Decision
- UONE
- ABOS Strong Buy
- Analyst Count
- UONE 0
- ABOS 3
- Target Price
- UONE N/A
- ABOS $8.00
- AVG Volume (30 Days)
- UONE 19.2K
- ABOS 185.0K
- Earning Date
- UONE 11-06-2025
- ABOS 11-11-2025
- Dividend Yield
- UONE N/A
- ABOS N/A
- EPS Growth
- UONE N/A
- ABOS N/A
- EPS
- UONE N/A
- ABOS N/A
- Revenue
- UONE $411,386,000.00
- ABOS N/A
- Revenue This Year
- UONE N/A
- ABOS N/A
- Revenue Next Year
- UONE N/A
- ABOS N/A
- P/E Ratio
- UONE N/A
- ABOS N/A
- Revenue Growth
- UONE N/A
- ABOS N/A
- 52 Week Low
- UONE $1.23
- ABOS $0.86
- 52 Week High
- UONE $2.02
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- UONE 41.14
- ABOS 41.32
- Support Level
- UONE $1.37
- ABOS $1.21
- Resistance Level
- UONE $1.63
- ABOS $1.47
- Average True Range (ATR)
- UONE 0.12
- ABOS 0.08
- MACD
- UONE -0.01
- ABOS -0.02
- Stochastic Oscillator
- UONE 18.75
- ABOS 15.38
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.